Continuous Thoracic Paravertebral Analgesia for Video-assisted Thoracoscopic Surgery
Status:
Terminated
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess:
- The impact of continuous thoracic paravertebral nerve blockade compared to intercostal
nerve blockade on the intensity of postoperative pain following VATS in subjects having
a Patient Controlled Analgesia (PCA) device as their primary analgesic modality.
- The impact of continuous thoracic paravertebral analgesia on length of stay, opioid
intake, respiratory function, incidence of side-effects and postoperative complications.
The basic hypothesis of this study is that continuous thoracic paravertebral nerve blockade
will provide superior postoperative analgesia following VATS when compared to intercostal
nerve blockade in patients having a PCA device as their primary analgesic modality. Superior
quality of analgesia should contribute to preserve pulmonary function, reduce opioid intake
and related side-effects and shorten the hospital stay.